Akari Therapeutics Plc (AKTX) Operating margin 2022–2023
Akari Therapeutics Plc (AKTX) operating margin by fiscal year — reported operating income divided by reported revenue.
-4568.4%FY2023 · since FY2022: -3799.4% → -4568.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -4568.4% | -769.0 pp |
| FY2022 | -3799.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AKTX financial trends
AKTX RevenueAKTX Net incomeAKTX Net marginAKTX Gross profitAKTX Gross marginAKTX Operating incomeAKTX Operating cash flowAKTX Free cash flowAKTX Capital expendituresAKTX Return on equityAKTX Stock buybacksAKTX Dividends paidAKTX Total assetsAKTX Total liabilitiesAKTX Shareholders’ equityAKTX overview →